Malign Melanomda Cerrahi Sonrası Adjuvan İmmunoterapi ve Kemoterapi Deneyimimiz
Open Access
- 26 December 2018
- journal article
- Published by Cagdas Tip Dergisi: Journal of Contemporary Medicine in Journal of Contemporary Medicine
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- The health burden and economic costs of cutaneous melanoma mortality by race/ethnicity–United States, 2000 to 2006Journal of the American Academy of Dermatology, 2011
- Recent trends in cutaneous melanoma incidence and death rates in the United States, 1992-2006Journal of the American Academy of Dermatology, 2011
- A Pooled Analysis of Eastern Cooperative Oncology Group and Intergroup Trials of Adjuvant High-Dose Interferon for MelanomaClinical Cancer Research, 2004
- Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684.Journal of Clinical Oncology, 1996
- Long-Term Adjuvant Therapy of High-Risk Malignant Melanoma with Interferon α2bJournal of Investigative Dermatology, 1990